Zhang, Ying
Ngo, Debby
Yu, Bing
Shah, Neomi A.
Chen, Han
Ramos, Alberto R.
Zee, Phyllis C.
Tracy, Russell
Durda, Peter
Kaplan, Robert
Daviglus, Martha L.
Rich, Stephen S.
Rotter, Jerome I.
Cai, Jianwen
Clish, Clary
Gerszten, Robert
Kristal, Bruce S.
Gharib, Sina A.
Redline, Susan
Sofer, Tamar
Funding for this research was provided by:
National Heart, Lung, and Blood Institute,United States (R35 HL135818, R35 HL135818, R35 HL135818)
National Heart, Lung, and Blood Institute (R01HL161012)
Article History
Received: 16 July 2022
Accepted: 13 December 2022
First Online: 16 December 2022
Competing interests
: BSK is the inventor on general metabolomics-related IP that has been licensed to Metabolon via Weill Medical College of Cornell University and for which he receives royalty payments via Weill Medical College of Cornell University. He also consults for and has a small equity interest in the company. Metabolon offers biochemical profiling services and is developing molecular diagnostic assays detecting and monitoring disease. Metabolon has no rights or proprietary access to the research results presented and/or new IP generated under these grants/studies. BSK's interests were reviewed by the Brigham and Women's Hospital and Partners Healthcare in accordance with their institutional policy. Accordingly, upon review, the institution determined that BSK's financial interest in Metabolon does not create a significant financial conflict of interest (FCOI) with this research. The addition of this statement where appropriate was explicitly requested and approved by BWH. SR reports receiving consulting fees from Jazz Pharma, Apnimed Inc, and Elli Lilly. These consultations were not related to metabolomics. DN reports that starting June 2021, she has been employed by Novartis with stock. No support for her work has come from Novartis, and this work is independent of her responsibilities as a Novartis employee and should not be affiliated with Novartis. YZ, BY, NAS, HC, ARR, PCZ, RT, PD, RK, MLD, SSR, JIR, JC, CC, RG, SAG, and TS report no conflict of interests.